The most common spliceosomal gene mutation is SF3B1, which is associated with ER+ breast cancer and seen in around 3% of ER+ tumours (Pereira et al. 2016), whereas mutations in SON and SAP130 appear to be associated with ER− disease (Maguire et al. 2015). The gene discussed is SF3B1; the disease is breast carcinoma.